Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized trial of ATRA plus chemotherapy for pancreatic cancer
2019-004231-23Phase 2Unknown
- Sponsor
- Queen Mary University of London
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tretinoin in pancreatic cancer (PC) (2 arms), sponsored by Queen Mary University of London. Primary endpoint: Progression-free survival. Status: unknown.
02
Drugs
tretinoin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on 2019-004231-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004231-23.